Crop Life Science Ltd
Chemicals & Petrochemicals | Small Cap
Crop Life Science Ltd demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation and efficient use of capital. Growth prospects are also promising, driven by significant increases in revenue, operating profit, and assets. However, liquidity is a concern, with low cash and operating cash flow ratios suggesting potential difficulties in meeting short-term obligations. Efficiency ratios also reveal challenges in inventory and receivables management. While the company's coverage ratios are adequate, there's room for improvement. Overall, Crop Life Science Ltd presents a picture of a company with robust growth and profitability potential, but with some vulnerabilities in short-term financial management.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio8.00
- Financial Ratio3.60
- Profitability Ratio9.60
- Efficiency Ratio3.67
- Coverage Ratio4.40
- Solvency Ratio10.00
- Liquidity Ratio3.86
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthBearish
Crop Life Science Ltd demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation and efficient use of capital. Growth prospects are also promising, driven by significant increases in revenue, operating profit, and assets. However, liquidity is a concern, with low cash and operating cash flow ratios suggesting potential difficulties in meeting short-term obligations. Efficiency ratios also reveal challenges in inventory and receivables management. While the company's coverage ratios are adequate, there's room for improvement. Overall, Crop Life Science Ltd presents a picture of a company with robust growth and profitability potential, but with some vulnerabilities in short-term financial management.
Overall Valuation Score
P/E RATIO (TTM)
10.78
Industry Median
16.36
Small Cap Median
16.22
P/E RATIO
11.37
P/B RATIO
0.89
Industry Median
2.47
Small Cap Median
2.47
P/S RATIO
0.37
Industry Median
1.58
Small Cap Median
1.58
Others
PEG RATIO
0.00
EV/EBITDA RATIO
4.21
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹44 as on Jun 20, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company demonstrates strong growth, with significant increases in revenue, operating profit, and assets. This indicates successful expansion and market penetration. However, the decline in earnings per share (EPS) growth raises concerns about profitability, needing closer monitoring.
| Growth Ratios | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue Growth Rate | 46.92 | 2.62 | 5.61 | |
| Operating Profit Growth Rate | 8.33 | 23.08 | 12.5 | |
| Earnings Per Share (EPS) Growth | 3.54 | -1.99 | 12.5 | |
| Asset Growth Rate | 76.47 | 1.11 | 14.29 | |
| Net Income Growth Rate | 50 | 0 | 0 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios present a mixed picture. While capital expenditures are well-managed, there are relatively low adjusted earnings per share, cash earnings per share, and book value per share. The company doesn't distribute dividends, which affects investor returns.
| Financial Ratios | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 3.33 | 3.31 | 3.36 | 3.42 |
| Cash Earnings Per Share (Cash EPS) | 6.67 | 5.29 | 6.47 | 6.47 |
| Book Value Per Share | 34.17 | 42.35 | 45.29 | 49.41 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 5 | 4.8 | 3.9 | 3.5 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company exhibits strong profitability, with high gross profit margin, return on capital employed (ROCE), return on equity (ROE), return on assets (ROA), operating margin and net margin. This indicates efficient operations, effective cost management, and a solid ability to generate profits from its investments and assets.
| Profitability Ratios | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Gross Profit Margin | 6.15 | 5.24 | 5.61 | 6.28 |
| Return on Capital Employed (ROCE) | 18.75 | 12 | 11 | 11 |
| Return on Equity (ROE) | 9.76 | 8.33 | 7.79 | 7.14 |
| Return on Assets (ROA) | 11.76 | 7.22 | 8.79 | 8.65 |
| Operating Margin | 9.23 | 6.81 | 8.16 | 8.7 |
| Net Margin | 3.08 | 3.14 | 3.06 | 2.9 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency ratios suggest some challenges in managing its assets and operations. While the fixed asset turnover ratio is average, the inventory and receivables turnover ratios are relatively low, and the days sales in inventory and receivable days are high. This indicates potential inefficiencies in inventory management and collection of receivables, which could tie up capital and impact profitability.
| Efficiency Ratios | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 8.12 | 4.9 | 5.16 | 7.39 |
| Inventory Turnover Ratio | 4.69 | 5.48 | 4.16 | 3.23 |
| Receivables Turnover Ratio | 3.97 | 3.47 | 2.68 | 2.9 |
| Days Sales in Inventory Ratio | 77.83 | 66.61 | 87.74 | 113 |
| Receivable Days | 92 | 105.19 | 136.19 | 125.86 |
| Capital Turnover Ratio | 2.71 | 2.33 | 2.33 | 2.33 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's coverage ratios suggest an adequate ability to meet its interest obligations, but there is no dividend coverage. While the interest coverage ratio is within an acceptable range, the lack of equity dividend coverage may impact investor confidence.
| Coverage Ratios | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Interest Coverage Ratio | 3 | 3.67 | 2.6 | 2.8 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company exhibits strong solvency, indicating a low level of debt relative to its equity and assets. This suggests a financially stable position with a reduced risk of financial distress. The company has a solid capital structure.
| Solvency Ratios | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debt Ratio | 0.15 | 0.12 | 0.08 | 0.06 |
| Debt to Equity Ratio | 0.18 | 0.14 | 0.09 | 0.06 |
| Equity Ratio | 0.85 | 0.88 | 0.92 | 0.94 |
| Debt To Asset Ratio | 0.07 | 0.06 | 0.04 | 0.02 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position indicates potential challenges in meeting its short-term obligations. While the current and quick ratios are within an acceptable range, the low cash and operating cash flow ratios raise concerns about the company's ability to cover immediate liabilities. This could impact the company's operational flexibility and its capacity to invest in growth opportunities.
| Liquidity Ratios | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Current Ratio | 1.59 | 1.42 | 1.46 | 1.5 |
| Quick Ratio | 1.11 | 1.02 | 0.96 | 0.9 |
| Cash Ratio | 0 | 0.02 | 0.01 | 0.03 |
| Operating Cash Flow Ratio | 0.04 | -0.08 | -0.02 | -0.07 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Aristo Bio-Tech & Lifescience Ltd | 7.93 | 19.45 | Undervalued | 16.00 | 10.55 | 7.00 |
| 2 | Ambey Laboratories Ltd | 7.08 | 19.30 | Neutral | 10.00 | 1.92 | N/A |
| 3 | Crop Life Science Ltd | 6.87 | 11.37 | Neutral | 18.00 | 4.08 | 6.00 |
The management of Crop Life Science Ltd presents a mixed picture. While revenue has grown, profit growth has been inconsistent. A stable promoter holding suggests confidence, but increasing borrowings and fluctuating cash conversion cycles are concerning. The management shows strengths in revenue generation and maintaining ownership but needs to address financial prudence and operational efficiency for sustainable growth.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth | 5.01% | Revenue expansion is evident |
| Promoter Holding | 70.01% | Indicates confidence and alignment with shareholders | |
| CONS | Borrowings | ₹ 44 Cr. | Leverage needs better control |
| Cash Conversion Cycle | 145 Days | Operational cycles are inefficient |
Financial Performance & Growth
Crop Life Science Ltd demonstrates moderate financial performance. Sales have increased, with a TTM growth of 5%. However, the compounded profit growth TTM is -1%, indicating a decline in profitability. The OPM has seen fluctuations, with a recent increase to 9% in Mar 2025 quarter but an annual OPM of 8% in Mar 2025. This inconsistent profit growth and fluctuating margins suggest some instability in financial performance.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Sales Growth % | 47.04% | 5.01% | |
| OPM % | 9% | 7% | 8% |
Capital Efficiency & Returns
The capital efficiency of Crop Life Science Ltd is mixed. The ROCE stands at 11% in Mar 2025. ROE for the last year is 8%. These figures suggest capital is being used, but there is room for improvement to enhance shareholder returns.
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| ROCE % | 12% | 11% |
| ROE % | 8% |
Financial Health & Prudence
Crop Life Science Ltd shows concerning trends in financial health. Borrowings have increased from ₹27 Cr in Mar 2023 to ₹44 Cr in Mar 2025. The company has not been paying dividends, with a dividend payout of 0% over the last three years. This increasing debt and lack of dividend payouts may raise concerns about the company's financial prudence.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Borrowings (₹ Cr) | 27 | 35 | 44 |
| Dividend Payout % | 0% | 0% | 0% |
Strategic & Operational Indicators
Operational efficiency is a challenge for Crop Life Science Ltd. The cash conversion cycle has increased from 116 days in Mar 2023 to 145 days in Mar 2025. Debtor days have increased from 92 days in Mar 2023 to 126 days in Mar 2025. These metrics suggest inefficiencies in managing working capital and operational cycles.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Cash Conversion Cycle (Days) | 116 | 115 | 145 |
| Debtor Days | 92 | 148 | 126 |
Crop Life Science Ltd faces moderate risks. While promoter holding remains stable, indicating confidence, increasing borrowings and a stretched cash conversion cycle pose financial and operational challenges. Fluctuations in operating profit margin and inconsistent profit growth further contribute to the risk profile. The absence of dividend payouts may also deter investors seeking regular income.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1043.43Bullish
- SMA 2043.02Bullish
- SMA 5043.18Bullish
- EMA 1043.58Bullish
- EMA 2043.35Bullish
- EMA 5043.30Bullish
- DEMA 1043.96Bullish
- DEMA 2043.55Bullish
- DEMA 5043.19Bullish
- TEMA 1044.21Bearish
- TEMA 2043.79Bullish
- TEMA 5043.38Bullish
- MACD0.19Bullish
- ADX20.52Weak Trend
- IndicatorValueSignal
- RSI56.62Neutral
- CCI83.18Neutral
- ROC 92.33Bullish
- ROC 144.76Bullish
- ROC 253.53Bullish
- Stoch K66.67Neutral
- Stoch D70.37Neutral
- IndicatorValueSignal
- BB Upper44.88Neutral
- BB Middle43.02Neutral
- BB Lower41.15Neutral
- ATR0.43Low Volatility
- IndicatorValueSignal
- MFI40.34Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1042.93Bullish
- SMA 2043.23Bullish
- SMA 5043.19Bullish
- EMA 1043.27Bullish
- EMA 2043.20Bullish
- EMA 5043.32Bullish
- DEMA 1043.49Bullish
- DEMA 2043.20Bullish
- DEMA 5042.96Bullish
- TEMA 1043.77Bullish
- TEMA 2043.33Bullish
- TEMA 50N/AN/A
- MACD0.03Bullish
- ADX19.29Weak Trend
- IndicatorValueSignal
- RSI56.49Neutral
- CCI58.39Neutral
- ROC 94.76Bullish
- ROC 14-2.22Bearish
- ROC 25N/ABearish
- Stoch K66.67Neutral
- Stoch D46.11Neutral
- IndicatorValueSignal
- BB Upper45.31Neutral
- BB Middle43.23Neutral
- BB Lower41.14Neutral
- ATR0.60Low Volatility
- IndicatorValueSignal
- MFI40.26Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1043.41Bullish
- SMA 2043.20Bullish
- SMA 5043.91Bullish
- EMA 1043.30Bullish
- EMA 2043.34Bullish
- EMA 5043.79Bullish
- DEMA 1043.35Bullish
- DEMA 2043.13Bullish
- DEMA 50N/AN/A
- TEMA 1043.50Bullish
- TEMA 2043.29Bullish
- TEMA 50N/AN/A
- MACD-0.11Bullish
- ADX14.50Weak Trend
- IndicatorValueSignal
- RSI52.15Neutral
- CCI54.92Neutral
- ROC 9-2.22Bearish
- ROC 14N/ABearish
- ROC 25N/ABearish
- Stoch K72.83Neutral
- Stoch D67.23Neutral
- IndicatorValueSignal
- BB Upper45.45Neutral
- BB Middle43.20Neutral
- BB Lower40.95Neutral
- ATR1.11Low Volatility
- IndicatorValueSignal
- MFI59.77Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1043.22Bullish
- SMA 2043.41Bullish
- SMA 5044.80Bearish
- SMA 10047.33Bearish
- SMA 20050.99Bearish
- EMA 1043.25Bullish
- EMA 2043.54Bullish
- EMA 5044.90Bearish
- EMA 10047.01Bearish
- EMA 20048.84Bearish
- DEMA 1043.08Bullish
- DEMA 2042.86Bullish
- DEMA 5042.50Bullish
- DEMA 10043.75Bullish
- DEMA 20047.24Bearish
- TEMA 1043.19Bullish
- TEMA 2043.06Bullish
- TEMA 5042.46Bullish
- TEMA 10041.84Bullish
- TEMA 20044.48Bearish
- MACD-0.48Bullish
- ADX11.39Weak Trend
- IndicatorValueSignal
- RSI50.56Neutral
- CCI87.68Neutral
- ROC 14N/ABearish
- ROC 25-2.22Bearish
- Stoch K67.23Neutral
- Stoch D63.21Neutral
- IndicatorValueSignal
- BB Upper45.42Neutral
- BB Middle43.41Neutral
- BB Lower41.40Neutral
- ATR1.80High Volatility
- IndicatorValueSignal
- MFI40.41Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 2045.25Bearish
- SMA 5050.62Bearish
- EMA 2045.37Bearish
- EMA 5048.03Bearish
- DEMA 2042.69Bullish
- DEMA 5045.95Bearish
- TEMA 2042.25Bullish
- TEMA 50N/AN/A
- MACD-1.94Bullish
- ADX16.22Weak Trend
- IndicatorValueSignal
- RSI43.02Neutral
- CCI-108.68Oversold
- ROC 14-7.53Bearish
- ROC 25-4.87Bearish
- Stoch K43.97Neutral
- Stoch D37.89Neutral
- IndicatorValueSignal
- BB Upper49.66Neutral
- BB Middle45.25Neutral
- BB Lower40.84Neutral
- ATR3.49Low Volatility
- IndicatorValueSignal
- MFI33.70Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 645.69Bearish
- SMA 1250.06Bearish
- SMA 2449.55Bearish
- EMA 645.55Bearish
- EMA 1247.57Bearish
- EMA 2447.65Bearish
- DEMA 642.84Bullish
- DEMA 1245.68Bearish
- DEMA 24N/AN/A
- TEMA 641.92Bullish
- TEMA 1243.46Bearish
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX9.66Weak Trend
- IndicatorValueSignal
- RSI46.52Neutral
- CCIN/AN/A
- ROC 256.40Bullish
- ROC 50N/AN/A
- Stoch KN/AN/A
- Stoch DN/AN/A
- IndicatorValueSignal
- BB Upper58.02Neutral
- BB Middle49.45Neutral
- BB Lower40.89Neutral
- ATR7.99Low Volatility
- IndicatorValueSignal
- MFI54.41Neutral